why choose us

First received: December 08, 2023

Clinical Trial: A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dyslipidemia

Study Type: INTERVENTIONAL


Official Title: A Phase IIb, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AZD0780 in Participants With Dyslipidem

Brief Summary: The primary purpose of this study is to measure the effect of different daily doses of AZD0780 on Low-Density Lipoprotein (LDL-C) levels compared with placebo in participants with dyslipidemia.The effect of AZD0780 versus placebo on other lipid parameters and inflammatory markers is also investigated.The concentration of AZD0780 in blood at specific timepoints is measured, and the safety and tolerability of AZD0780 will be evaluated.There is a follow-up after end of treatment, but expanded access is not…

Read more